These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9869485)

  • 1. Z2D3 imaging: fringe or frontier?
    Strauss HW
    J Nucl Cardiol; 1998; 5(6):626-8. PubMed ID: 9869485
    [No Abstract]   [Full Text] [Related]  

  • 2. Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells.
    Carrió I; Pieri PL; Narula J; Prat L; Riva P; Pedrini L; Pretolani E; Caruso G; Sarti G; Estorch M; Berná L; Riambau V; Matías-Guiu X; Pak C; Ditlow C; Chen F; Khaw BA
    J Nucl Cardiol; 1998; 5(6):551-7. PubMed ID: 9869476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments.
    Narula J; Petrov A; Bianchi C; Ditlow CC; Lister BC; Dilley J; Pieslak I; Chen FW; Torchilin VP; Khaw BA
    Circulation; 1995 Aug; 92(3):474-84. PubMed ID: 7634463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximizing radiotracer delivery to experimental atherosclerotic lesions with high-dose, negative charge-modified Z2D3 antibody for immunoscintigraphic targeting.
    Narula J; Petrov A; Ditlow C; Pak KY; Chen FW; Khaw BA
    J Nucl Cardiol; 1997; 4(3):226-33. PubMed ID: 9199260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma imaging of atherosclerotic lesions: the role of antibody affinity in in vivo target localization.
    Narula J; Petrov A; O'Donnell SM; Ditlow C; Pieslak I; Dilley J; Chen F; Khaw BA
    J Nucl Cardiol; 1996; 3(3):231-41. PubMed ID: 8805743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive detection of atherosclerotic lesions by 99mTc-based immunoscintigraphic targeting of proliferating smooth muscle cells.
    Narula J; Petrov A; Pak KY; Ditlow C; Chen F; Khaw BA
    Chest; 1997 Jun; 111(6):1684-90. PubMed ID: 9187194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical approach to planar and SPECT imaging of 111In-CYT-103.
    Collier BD; Trembath LA; Liu Y; Turoglu HT; Patel N; Thakur S
    Targeted Diagn Ther; 1992; 6():191-210. PubMed ID: 1576346
    [No Abstract]   [Full Text] [Related]  

  • 8. Smooth muscle cell proliferation index correlates with 111In-labeled antibody Z2D3 uptake in a transplant vasculopathy swine model.
    Jimenez J; Donahay T; Schofield L; Khaw BA; Johnson LL
    J Nucl Med; 2005 Mar; 46(3):514-9. PubMed ID: 15750167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nuclear medicine diagnosis in the characterization of atherosclerotic plaques].
    Richter WS; Munz DL
    Dtsch Med Wochenschr; 1997 Jun; 122(23):761-6. PubMed ID: 9229555
    [No Abstract]   [Full Text] [Related]  

  • 10. Superiority of SPET to planar imaging in the detection of colorectal carcinomas with 111In monoclonal antibodies.
    Nabi HA; Erb DA; Cronin VR
    Nucl Med Commun; 1995 Aug; 16(8):631-9. PubMed ID: 7491174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-111 CYT-103 immunoscintigraphy of isolated splenic metastasis from ovarian carcinoma.
    Nguyen BD; Regan F
    Clin Nucl Med; 1997 Apr; 22(4):256-7. PubMed ID: 9099487
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible false-positive metastatic prostate cancer on an In-111 capromab pendetide scan as a result of a pelvic kidney.
    Valliappan S; Joyce JM; Myers DT
    Clin Nucl Med; 1999 Dec; 24(12):984-5. PubMed ID: 10595486
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical applications of indium-111-labeled monoclonal antibody imaging in colorectal cancer patients.
    Abdel-Nabi H; Doerr RJ
    Semin Nucl Med; 1993 Apr; 23(2):99-113. PubMed ID: 8511606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can molecular imaging predict in-stent restenosis?
    Bax JJ; Oemrawsingh PV
    J Nucl Med; 2004 Feb; 45(2):300-1. PubMed ID: 14960652
    [No Abstract]   [Full Text] [Related]  

  • 15. BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy.
    Parisi A; Bartolazzi A; Bonino C; Camagna M; DeMonte LB; Lombardi A; Natali PG; Paganelli G; Tarditi L; Vassarotto C
    Year Immunol; 1993; 7():96-105. PubMed ID: 8372516
    [No Abstract]   [Full Text] [Related]  

  • 16. Current status of radioimmunodetection.
    Larson SM; Divgi C; Scott A; Daghighian F; Macapinlac H; Welt S
    Nucl Med Biol; 1994 Jul; 21(5):721-9. PubMed ID: 9241648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appearance of a hepatic hemangioma on prostate immunoscintigraphy. Value of early images.
    Krynyckyi BR; Ganeles A; Freeman LM; Zuckier LS
    Clin Nucl Med; 1996 Jul; 21(7):541-3. PubMed ID: 8818467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer.
    Volpe CM; Abdel-Nabi HH; Kulaylat MN; Doerr RJ
    Ann Surg Oncol; 1998 Sep; 5(6):489-94. PubMed ID: 9754756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Imaging of myocardial necrosis--indium-111 labeled antimyosin monoclonal antibody imaging using single-photon emission computed tomography].
    Yamada T; Matsumori A
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):569-73. PubMed ID: 12436583
    [No Abstract]   [Full Text] [Related]  

  • 20. Single photon emission computerized tomography with capromab pendetide plus computerized tomography image set co-registration independently predicts biochemical failure.
    Ellis RJ; Zhou EH; Fu P; Kaminsky DA; Sodee DB; Faulhaber PF; Bodner D; Resnick MI
    J Urol; 2008 May; 179(5):1768-73; discussion 1773-4. PubMed ID: 18343445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.